Kirkland, Skadden Steer Permira's $2.4B Cambrex Buy
Cambrex said Wednesday an affiliate of private equity firm Permira will acquire the small-molecule drug company in a $2.4 billion deal, with Kirkland & Ellis LLP steering the seller and Skadden...To view the full article, register now.
Already a subscriber? Click here to view full article